The genetics of cystic fibrosis lung disease

被引：20
|
作者：
Davidson, DJ [1 ]
Porteous, DJ [1 ]
机构：
[1] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
THORAX | 1998年 / 53卷 / 05期
关键词：
D O I：
10.1136/thx.53.5.389
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：389 / 397
页数：9
相关论文
共 50 条
  • [21] Cystic fibrosis lung disease: Current perspectives
    Jung, Jin-A
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (01): : 3 - 8
  • [22] Antioxidant supplementation for lung disease in cystic fibrosis
    Ciofu, Oana
    Smith, Sherie
    Lykkesfeldt, Jens
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [23] Role of corticosteroids in cystic fibrosis lung disease
    BalfourLynn, IM
    Dinwiddie, R
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 : 8 - 13
  • [24] Genetic therapies for cystic fibrosis lung disease
    Sinn, Patrick L.
    Anthony, Reshma M.
    McCray, Paul B., Jr.
    HUMAN MOLECULAR GENETICS, 2011, 20 : R79 - R86
  • [25] Update on pathogenesis of cystic fibrosis lung disease
    Donaldson, SH
    Boucher, RC
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (06) : 486 - 491
  • [26] Emerging therapies for cystic fibrosis lung disease
    Grasemann, Hartmut
    Ratjen, Felix
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 653 - 659
  • [27] An overview of the pathogenesis of cystic fibrosis lung disease
    Boucher, RC
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (11) : 1359 - 1371
  • [28] Emerging therapies for cystic fibrosis lung disease
    Rubin, BK
    CHEST, 1999, 115 (04) : 1120 - 1126
  • [29] PERFUSION MRI IN CYSTIC FIBROSIS LUNG DISEASE
    Wielpuetz, Mark O.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S204 - S204
  • [30] Antioxidant supplementation for lung disease in cystic fibrosis
    Ciofu, Oana
    Lykkesfeldt, Jens
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
12345